An encouraging report in the NY Times described a new collaborative effort involving several major pharmaceutical companies. The project, called TransCelerate, is intended to make clinical trials more efficient. It would include attempts to develop standard protocols for trials and an internet portal for sharing information. In essence, this is a first step in bringing clinical trials out from behind the walls of corporate secrecy and into the pre-competitive space. This is a welcome development (if it actually works).